Advantages and disadvantages of the meta-analysis approach

被引:107
作者
Fagard, RH [1 ]
Staessen, JA [1 ]
Thijs, L [1 ]
机构
[1] KATHOLIEKE UNIV LEUVEN,FAC MED,DEPT MOL & CARDIOVASC RES,HYPERTENS & CARDIOVASC REHABIL UNIT,B-3001 LOUVAIN,BELGIUM
关键词
meta-analysis; statistical power; clinical trials;
D O I
10.1097/00004872-199609002-00004
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Advantages of meta-analysis Literature reviews have traditionally been largely narrative, Meta-analysis now offers the opportunity to critically evaluate and statistically combine results of comparable studies or trials. Its major purposes are to increase the numbers of observations and the statistical power, and to improve the estimates of the effect size of an intervention or an association. Methods There is, as yet, no unanimously accepted strategy for performing a meta-analysis but researchers agree that each meta-analysis should be conducted like a scientific experiment and begin with a protocol, which clearly states its aim and methodology, Meta-analysts disagree on the criteria for inclusion or exclusion of primary studies, with relation to publication status, comparability and required scientific quality, but sensitivity analyses make it possible to assess the impact of various selection criteria on the results, Several statistical methods have been developed to analyse data extracted from the literature; more recently, meta-analyses have also been performed on individual subject data. Conclusions Meta-analysis is superior to narrative reports for systematic reviews of the literature, but its quantitative results should be interpreted with caution even when the analysis is performed according to rigorous rules.
引用
收藏
页码:S9 / S12
页数:4
相关论文
共 29 条
[1]  
BULPITT CJ, 1988, LANCET, V2, P93
[2]   BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .2. SHORT-TERM REDUCTIONS IN BLOOD-PRESSURE - OVERVIEW OF RANDOMIZED DRUG TRIALS IN THEIR EPIDEMIOLOGIC CONTEXT [J].
COLLINS, R ;
PETO, R ;
MACMAHON, S ;
HEBERT, P ;
FIEBACH, NH ;
EBERLEIN, KA ;
GODWIN, J ;
QIZILBASH, N ;
TAYLOR, JO ;
HENNEKENS, CH .
LANCET, 1990, 335 (8693) :827-838
[3]   REVERSAL OF LEFT-VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS - A METAANALYSIS OF 109 TREATMENT STUDIES [J].
DAHLOF, B ;
PENNERT, K ;
HANSSON, L .
AMERICAN JOURNAL OF HYPERTENSION, 1992, 5 (02) :95-110
[4]   SYSTEMATIC REVIEWS - IDENTIFYING RELEVANT STUDIES FOR SYSTEMATIC REVIEWS [J].
DICKERSIN, K ;
SCHERER, R ;
LEFEBVRE, C .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 309 (6964) :1286-1291
[5]   PUBLICATION BIAS IN CLINICAL RESEARCH [J].
EASTERBROOK, PJ ;
BERLIN, JA ;
GOPALAN, R ;
MATTHEWS, DR .
LANCET, 1991, 337 (8746) :867-872
[6]   A METHOD FOR META-ANALYSIS OF EPIDEMIOLOGICAL-STUDIES [J].
EINARSON, TR ;
LEEDER, JS ;
KOREN, G .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1988, 22 (10) :813-824
[7]   MULTIPLE STANDARDIZED CLINIC BLOOD PRESSURES MAY PREDICT LEFT-VENTRICULAR MASS AS WELL AS AMBULATORY MONITORING - A METAANALYSIS OF COMPARATIVE-STUDIES [J].
FAGARD, R ;
STAESSEN, J ;
THIJS, L ;
AMERY, A .
AMERICAN JOURNAL OF HYPERTENSION, 1995, 8 (05) :533-540
[8]   THE RELATIONSHIPS BETWEEN LEFT-VENTRICULAR MASS AND DAYTIME AND NIGHTTIME BLOOD PRESSURES - A METAANALYSIS OF COMPARATIVE-STUDIES [J].
FAGARD, R ;
STAESSEN, JA ;
THIJS, L .
JOURNAL OF HYPERTENSION, 1995, 13 (08) :823-829
[9]  
FAGARD RH, 1993, J HYPERTENS, V11, pS47
[10]   REVERSIBILITY OF LEFT-VENTRICULAR HYPERTROPHY BY ANTIHYPERTENSIVE DRUGS [J].
FAGARD, RH .
NETHERLANDS JOURNAL OF MEDICINE, 1995, 47 (04) :173-179